Kerja Sepenuh Masa, Program Lead — Oncology di Diode Bio - Maukerja

Diode Bio is a clinical-stage company that co-develops and co-invests in funding-constrained Phase I–II oncology candidates with pharmaceutical partners, accelerating medicines that might otherwise be deprioritized or delayed. Founded by physician-scientists and industry leaders, the company combines strengths in clinical science, operational execution, and partnering across APAC and global markets. Its cross-functional team spans clinical operations, regulatory affairs, compliance, and finance, with deep experience in pharmaceutical R&D and clinical development. Diode Bio is supported by global pharma executives, venture investors, CRO operators, and leading academic clinicians and scientists. The company integrates artificial intelligence across asset development, from opportunity discovery to clinical execution, to enhance decision-making and trial performance.

Own the clinical development and operational execution of our oncology asset portfolio across APAC. You'll be the primary interface with our preferred CRO partner (Novotech) and regional KOL networks, driving Phase 1–2 programmes forward in close alignment with our pharma co-development partners.

Lead Phase 1–2 programme planning and execution across APAC sitesPrimary operational interface with Novotech CRO and regional oncology KOLs and PIsOwn timelines, risk registers, budgets, and regulatory milestone trackingCollaborate with scientific advisors on protocol design and development strategyPresent programme updates to Diode Bio leadership and pharma co-development partnersSupport IND/CTA preparation and regulatory authority engagement

• 6–12 years in pharma, biotech, or CRO with oncology focusHands-on Phase 1–2 trial management, ideally with APAC site experienceStrong CRO management and KOL engagement skillsMD, PhD, or PharmD preferred; APAC regulatory familiarity an advantage